Highlights

  • Ramsay reported 1H FY26 underlying NPAT after non-controlling interests of A$200.9 million, up 5.0% on the prior corresponding period.
  • Australian underlying EBIT increased 7.1% in 1H FY26, supported by activity growth, higher acuity, private Health Insurance indexation and cost management.
  • Ramsay opened Ramsay Private at Joondalup Health Campus in February 2026 and continued targeted Investment in procedural capacity.
  • The company announced a proposed demerger of its 52.79% interest in Ramsay Santé, subject to Shareholder and other required approvals.
  • Capital allocation and utilisation remain central to Ramsay’s Australian transformation program.

Ramsay Health Care provides private healthcare across Australia, the UK and Europe. Its 2026 disclosures show a Business focused on improving performance in its Australian hospital network while reshaping the group structure through the proposed separation of Ramsay Santé. The period also featured continued investment in procedural capacity, cost control and portfolio discipline.

Australian Operations Support Earnings Progress

For the six months ended 31 December 2025, reported in February 2026, Ramsay recorded total Revenue and other income of A$4,763.6 million and underlying EBIT of A$420.0 million. Underlying NPAT after non-controlling interests was A$200.9 million, representing a 5.0% increase from the prior corresponding period.

Australian underlying EBIT increased 7.1%. Ramsay attributed the improvement to activity growth across private and public work, higher acuity, improved private health insurance indexation and cost management. Excluding Joondalup, Australian EBIT margins increased by 40 basis points. The Joondalup contribution was affected by a new funding mechanism, partly offset by operational actions.

Capacity Investment Remains Focused on Major Hospitals

Ramsay continued to direct development spending toward procedural capacity in larger hospitals and growth catchments. Ramsay Private at Joondalup Health Campus opened on 18 February 2026, with the development completed around A$14 million under budget. The company also said 23 new theatres and procedure rooms were scheduled to open during FY26.

Full-year Australian development Capital expenditure was expected to be A$170-190 million, below the company’s previous guidance range. Management linked this approach to greater utilisation of existing Assets and a more selective capital allocation process.

Proposed Ramsay Santé Demerger Reshapes Group Structure

On 20 February 2026, Ramsay announced a proposal to distribute its entire 52.79% shareholding in Ramsay Santé to Ramsay shareholders on a pro rata basis through an in-specie distribution implemented by a scheme of arrangement. The proposed separation is intended to simplify Ramsay’s portfolio and allow greater management focus on the Australian hospital business.

The transaction remains subject to shareholder and other required approvals. Ramsay has indicated that the different geographic focus, strategies and capital profiles of Ramsay and Ramsay Santé are central to the rationale for the proposed separation.

Key Insights

Ramsay’s 2026 reporting points to two linked priorities: lifting operating performance in Australia and simplifying the group’s structure. Australian activity, acuity and cost management supported earnings growth in the first half, while targeted capacity additions were concentrated in major hospitals. The proposed Ramsay Santé demerger would further increase the group’s focus on Australia if completed, making execution of the domestic transformation program a central Factor in future reporting.